News
News
- Basilea reports activity of derazantinib in preclinical models of gastric cancer at ASCO Gastrointestinal Cancers Symposium
01/23/2020 / 07:15 - GlobeNewswire - Basilea announces clinical supply agreement for its planned study FIDES-03 with derazantinib in gastric cancer
01/22/2020 / 07:15 - GlobeNewswire - BridgeBio Pharma’s Gene Therapy Subsidiaries Enter Strategic Partnership with Catalent for Dedicated Gene Therapy Development and Manufacturing Capacity
01/10/2020 / 13:30 - GlobeNewswire - Amunix Pharmaceuticals Announces Technology Licensing Agreement with Roche to Advance Novel Therapeutics Outside Oncology
01/10/2020 / 13:00 - GlobeNewswire - Basilea at the 38th Annual J. P. Morgan Healthcare Conference – significant progress in Cresemba commercialization and R&D portfolio in 2019
01/08/2020 / 07:15 - GlobeNewswire - CRISPR Therapeutics to Present at the Goldman Sachs 12th Annual Healthcare CEOs Unscripted: A View from the Top Conference
01/06/2020 / 22:05 - GlobeNewswire - Europe closes mostly higher on trade optimism
12/23/2019 / 17:31 - TeleTrader - Roche enters $1.15B partnership with Sarepta
12/23/2019 / 07:47 - TeleTrader - Sarepta Therapeutics Announces Partnership with Roche in Territories Outside the United States for its Investigational Micro-dystrophin Gene Therapy for Duchenne Muscular Dystrophy, SRP-9001
12/23/2019 / 07:00 - GlobeNewswire - BridgeBio Pharma, Inc. Appoints Industry Leader Jennifer Cook as New Board Member
12/16/2019 / 13:30 - GlobeNewswire
Real-time